At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
A sterile solution containing sodium carboxymethylcellulose and glycerin, preserved with PURITE® +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms
In Brief
A Phase 4 clinical trial evaluating A sterile solution containing sodium carboxymethylcellulose and glycerin, preserved with PURITE® and Sodium hyaluronate for Dry Eye Syndromes. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This study evaluates the performance and acceptance of Optive versus Hylocomod eyedrops, when administered for one month to patients with mild to moderate dry eye symptoms, with and without contact lenses.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
Primary CompletionJun 2008
First PostedSep 2008
TodayJul 2026
First PostedSep 29, 2008
Enrollment StartAug 1, 2007
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 17.8 years ago
Interventions
A sterile solution containing sodium carboxymethylcellulose and glycerin, preserved with PURITE®drug
Eyedrops as required, but at least 3 times per day
Sodium hyaluronatedrug
Eyedrops as required, but at least 3 times per day